Today: 29 June 2026
Browse Category

NSE:VEDL 29 October 2025 - 10 December 2025

Vedanta Share Price Today: Q2 FY26 Results, Demerger Timeline, Analyst Targets and Key Risks (10 December 2025)

Vedanta Share Price Today: Q2 FY26 Results, Demerger Timeline, Analyst Targets and Key Risks (10 December 2025)

Vedanta Limited traded near ₹528 on 10 December 2025, close to its 52-week high, after posting record Q2 FY26 EBITDA of ₹11,612 crore. Net profit for the quarter fell 38% year-on-year to ₹3,479 crore. The stock is up over 40% from its 52-week low, with a dividend yield around 8–9%. High trading volumes and institutional activity continue amid ongoing regulatory scrutiny and short-seller allegations.
10 December 2025
··
Vedanta Limited Share Price Today: De‑merger, Incab Deal and Analyst Targets Shape VEDL’s 2026 Outlook

Vedanta Limited Share Price Today: De‑merger, Incab Deal and Analyst Targets Shape VEDL’s 2026 Outlook

Vedanta Limited traded near ₹525.5 on the NSE late morning 5 December 2025, down about 1% from the previous close. The stock touched a 52-week high above ₹540 on 4 December, lifted by progress on its $20 billion de-merger and a new power cables acquisition. Investors remain cautious over high debt, commodity price swings, and pending regulatory approvals. Market cap stands near ₹2.1 lakh crore.
5 December 2025
·
Vedanta Share Price Today Near Record High: Q2 FY26 Results, Demerger Delay and Analyst Forecasts Explained (1 December 2025)

Vedanta Share Price Today Near Record High: Q2 FY26 Results, Demerger Delay and Analyst Forecasts Explained (1 December 2025)

Vedanta Limited traded near a record high at ₹533–535 on the NSE as of late morning 1 December 2025, after reporting all-time high Q2 revenue of ₹39,218 crore and EBITDA of ₹11,612 crore. Net profit fell sharply due to large exceptional items, and the company’s demerger timeline has slipped into 2026. Shares are up about 24% over three months. Market cap stands near ₹2.06 lakh crore.
1 December 2025
·
Vedanta’s Big Split Stumbles: Govt Roadblocks, Fresh Delays & What It Means for Investors

Vedanta’s Big Split Stumbles: Govt Roadblocks, Fresh Delays & What It Means for Investors

India’s SEBI has approved key documents for Vedanta Ltd’s demerger, but final clearance depends on the National Company Law Tribunal, which delayed its hearing to November 12 after a bench reconstitution. The government has raised objections, alleging Vedanta altered the scheme and concealed liabilities. The demerger deadline has shifted to March 2026. Vedanta shares remain near a 52-week high despite the delays.
29 October 2025
··
1 2

Stock Market Today

  • Singular Health Group Applies for Quotation of Additional ASX Shares
    June 28, 2026, 8:02 PM EDT. Singular Health Group Ltd has applied for the quotation of 2,571,222 new ordinary fully paid shares on the Australian Securities Exchange (ASX). This move aims to expand the company's market presence and increase liquidity. The application signifies the firm's intent to raise capital or satisfy existing commitments through share issuance. Investors will monitor the impact on share supply and potential dilution. The announcement reflects Singular Health's ongoing efforts to support its growth and operational strategies.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop